Transgenic bovine |
| In accordance with the above objects, the invention includes transgenes for producing recombinant ... |
|
Lipid binding protein 4 |
| 1. An isolated polypeptide selected from one of the groups consisting of: (a) a polypeptide encoded ... |
|
Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies |
| OF THE PREFERRED EMBODIMENTS I. Definitions An "ErbB receptor" is a receptor protein tyrosine ... |
|
Tumor killing effects of enterotoxins, superantigens, and related compounds |
| What is claimed is: 1. A mammalian cell comprising an exogenous nucleic acid encoding a ... |
|
Vaccine against Staphylococcus intoxication |
| The present invention satisfies the need discussed above. The present invention relates to a method ... |
|
Mutants of Streptococcal toxin C and methods of use |
| OF THE INVENTION This invention is directed to mutant SPE-C toxins and fragments thereof, vaccine ... |
|
Mutants of Streptococcal toxin A and methods of use |
| OF THE INVENTION This invention is directed to mutant SPE-A toxins and fragments thereof, vaccine ... |
|
Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof |
| It has now been surprisingly found that polarisation of the T.sub.H1 immune response over the T.sub.... |
|
|
Production and use of monoclonal antibodies to phosphotyrosine-containing proteins
| Details |
Inventors: Frackelton, Jr., A. Raymond; Eisen, Herman N.; Ross, Alonzo H.;
Assignee: Massachusetts Institute of Technology (Cambridge, MA)
Primary Examiner:
Assistant Examiner:
Attorney, Agent or Firm:
A hybridoma cell line is disclosed that secretes monoclonal antibodies which serve as a high titer, reproducible, biological reagent useful in biological/medical research for isolating and identifying phosphotyrosine-containing proteins. In addition, the antibodies have potential uses in diagnosis of a variety of diseases, including certain cancers. The antibodies, which have demonstrated affinity for a variety of molecules containing o-phosphotyrosine residues, were prepared using a synthetic analog, p-azobenzyl phosphonate (ABP) covalently linked to a carrier protein, as the antigen. |
|
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS A hybridoma secreting monoclonal antibodies that bind to PT-residues of PT-proteins was isolated from a fusion of Sp 2/0 cells with spleen cells of mice immunized with the ABP analog of the target antigenic determinant. Male 8-weeks old Balb/c mice were immunized intradermally and in their footpads with 100 . mu. g of Keyhole Limpet Hemocyanin (KLH) carrier derivatized with about 30 ABP groups per 100,000 MW of KLH and emulsified in complete Freunds adjuvant. The mice were injected again about 3 months later with the same antigen. Four days later, spleens were removed from four mice killed by ether and cell suspensions prepared. The spleen cells (1. 6. times. 10. sup. 8) from immunized mice and the Sp 2/0 fusing partner cells (8. times. 10. sup. 7) were each washed three times with serum free Dulbecco's Modified Eagles (DME) media, then mixed together and centrifuged at 400. times. g for 5 minutes at room temperature. The cell pellet was resuspended in 0. 2 ml DME and re-centrifuged at 400. times. g for 10 minutes. The spleen and Sp 2/0 cells were fused using polyethylene glycol (MW=1500, Behringwerke). Fused cells were grown in HAT medium. Hybrids that secrete anti-ABP antibody were detected by a solid phase radioimmunoassay. Wells of plates (Dynatech) were coated overnight with ABP-BSA (50 . mu. l of 2 . mu. g ml. sup. -1 solution in PBS), then washed with PBS and a 1% BSA solution in PBS. Twenty-five microliters of 1% of BSA and 20 . mu. l of culture fluid were pipetted into each well and incubated for 3 hours at 37. degree. C. The wells were next washed 2-times with PBS, and 50 . mu. l of a solution containing . sup. 125 I-labeled rabbit anti-mouse Ig (20 . mu. g ml. sup. -1, 2. 5. times. 10. sup. 4 cpm ng. sup. -1) (Gateway, affinity purified on a normal mouse Ig-Sepharose 4B immunosorbent and labeled by the chloramine T method) were added to each well and incubated 4 hours at 37. degree. C. The wells were washed three times with PBS, and remaining . sup. 125 I was determined in a scintillation spectrometer
|
| Related patents |
|
|
Trichothecene antibody conjugates
I claim: 1. A conjugate of a trichothecene and an antibody or antibody fragment, said antibody or antibody fragment being capable of specifically binding to a defined ...
|
|
|
Monoclonal antibody to human protein C
What is claimed is: 1. A monoclonal antibody which is specific to human protein C which has calcium bound at the gamma-carboxyglutamic acid (Gla) domain and does not ...
|
|
|
Method for providing a cell culture from a transgenic non-human mammal
We claim: 1. A method of providing a cell culture comprising (1) providing a transgenic non-human mammal, all of whose germ cells and somatic cells contain a recombinant ...
|
|
|
Method of gene transfer into chickens and other avian species
A method is described for introducing foreign genes or foreign nucleic acid sequences into somatic and/or germ cells of the chicken and other avian species. A ...
|
|
|
DNA vector with isolated CDNA gene encoding metallopanstimulin
The present invention is based upon the discovery of a new and heretofore unrecognized type of cellular mRNA sequence and its encoded protein, designated as ...
|
|
|
Method for preparing immunoglobulin fragments
Pursuant to the present invention, there is provided an improved method for specific fragmentation of immunoglobulins and recovery of the fragments. Through the use of ...
|
|
|
Morpholino-subunit combinatorial library and method
The invention includes, in one aspect, a combinatorial library of non-biological oligomers formed predominantly of morpholino subunit structures of the form: ##STR1## ...
|
|
|
Method of producing transgenic animals
What is claimed is: 1. A method for transferring DNA into fertilized eggs of a non-human mammal, comprising: subjecting a mixture of said DNA and said fertilized eggs to ...
|
|
|
Humanized immunoglobulins
OF THE INVENTION In accordance with the present invention, novel means of designing humanized immunoglobulins capable of specifically binding to a predetermined antigen ...
|
|
|
Recombinant retroviruses
Briefly stated, the present invention provides recombinant retroviruses carrying a vector construct capable of preventing, inhibiting, stabilizing or reversing ...
|
|
|